Viral hepatitis poses huge burden to the health care delivery system as well as to the economy of
Bangladesh. Hepatitis E virus is the leading cause of acute hepatitis in this country, however with
the improvement of economic status and sanitation this seems to be on the decline. Hepatitis B virus
remains the leading cause in all forms of chronic liver diseases in this country. This virus has been
extensively studied in Bangladesh, including from epidemiology to pathogenosis. Clinical trials with
innovative therapy conducted in Bangladesh have shown promise. Hepatitis C virus follows hepatitis B
virus as the second commonest cause of chronic liver diseases here. However patients in Bangladesh
have started benefitting from the local generic versions of the newly introduced direct acting anti-virals.